A live recombinant anguillid herpesvirus 1 useful for the prevention or therapy of a disease caused by anguillid herpes virus 1 and use thereof

TW202629794APending Publication Date: 2026-07-16VAL

0 Cites 0 Cited by

Patent Information

Application Number: TW114141327
Authority / Receiving Office: TW · TW
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2024-10-25
Filing Date: 2025-10-27
Publication Date: 2026-07-16

Application Information

Patent Timeline

25 Oct 2024

Priority

27 Oct 2025

Application

TW114141327

16 Jul 2026

Publication

TW202629794A

IPC: C12N15/33; A61K39/12; A61P31/12

Inventors: 范德普拉申阿蘭

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

One aspect of the invention provides live recombinant eel herpesvirus 1 (AngHV-1) comprising a dysfunctional open reading frame 35 (ORF35) genome. Another aspect provides products and compositions derived from or containing live recombinant AngHV-1. Uses and methods for vaccination and disease treatment in fish, particularly eels, using live recombinant AngHV-1 are also provided.

Need to check novelty before this filing date? Find Prior Art